Altamira Therapeutics Ltd - Company Profile

Powered by

All the data and insights you need on Altamira Therapeutics Ltd in one report.

  • Save hours of research time and resources with
    our up-to-date Altamira Therapeutics Ltd Strategy Report

  • Understand Altamira Therapeutics Ltd position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Altamira Therapeutics Ltd: Executives

The following section provides information on Altamira Therapeutics Ltd’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Altamira Therapeutics Ltd's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Thomas Meyer

Chief Executive Officer; Chairman Executive Board Since: 2003 Age: 55

Mr. Thomas Meyer has been the Chief Executive Officer, the Chairman and the Founder of Auris Medical Holding AG since April 2003. Prior to this, he served as the Chief Executive Officer at Disetronic Group. He also served at Disetronic from 1988 to 2000 as a member of the Board of Directors, Deputy Chief Executive Officer and Chief Executive Officer.

Read Hide full bio of Thomas Meyer

Covadonga Paneda

Chief Operating Officer Senior Management Since: 2023 Age: 49

Ms. Covadonga Paneda has been the Chief Operating Officer of the company since 2023. Prior to this, she served as R&D Manager at Sylentis S.A. Previously, she served as Director of Development at Limm Therapeutics. Most recently s she joined as Chief Development Officer of the company since 2022.

Read Hide full bio of Covadonga Paneda

Samuel A. Wickline

Chief Scientific Officer Senior Management Since: 2021 Age: 69

Mr. Samuel A. Wickline has been the Chief Scientific Officer of the company since 2021. Prior to this, he was the founder of Trasir Therapeutics, Inc., which the company acquired in 2021. He was also the Director of the USF Health Heart Institute.

Read Hide full bio of Samuel A. Wickline

Marcel Gremaud

Chief Financial Officer Senior Management Since: 2021 Age: 65

Calvin W. Roberts

Director Non Executive Board Since: 2015 Age: 69
Gain a 360-degree view of Altamira Therapeutics Ltd and make more informed decisions for your business Gain a 360-degree view of Altamira Therapeutics Ltd and make more informed decisions for your business Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Start of HubSpot Embed Code End of HubSpot Embed Code